HKA significant number of mainland Chinese companies seeking to list on the Hong Kong stock exchange are facing potential delays due to a backlog in approvals. Over 430 companies are currently in the IPO pipeline, with more than 30, including major firms like Qiandama and EVE Energy, approaching the six-month deadline for their applications. The situation reflects a stricter regulatory environment, as the China Securities Regulatory Commission (CSRC) now requires pre-approval before HKEX can proceed with listing hearings. Experts note that industries aligned with national policies—such as AI, robotics, semiconductors, and biotechnology—are more likely to receive favorable treatment. While some companies risk having to resubmit updated financial data if their applications expire, industry consultants suggest that successful listings can still proceed if core fundamentals remain stable.
Bias read (Center): The article presents a balanced overview of the regulatory challenges facing mainland Chinese companies seeking to list in Hong Kong. It includes perspectives from industry experts and highlights both the difficulties and potential pathways for success. There is no overt ideological slant toward any
